Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Clifford M. Thornton

Clifford M. Thornton

Cardiovascular Device & Imaging Marketing Consultant & Medical Journalist, USA

Title: The Future of Cardiology (2018-2030): Advanced Treatments to Combat the Global Advance of Cardiovascular Diseases

Biography

Biography: Clifford M. Thornton

Abstract

Statement of the Problem: The incidence of Cardiovascular Diseases (CVDs) is rising globally, and rapidly. As a result, this is not just a health issue, but an economic one as related costs are ballooning to economically unsustainable levels. For example, in the U.S., total healthcare expenditures, which are significantly driven by heart disease, are nearing 20% of the total gross domestic national product (GDP). As developing economies experience similar increases in CVDs, it will become more challenging to meet their populations’ health needs while sustaining their economies. Some of the key related statistics:

  • On a worldwide basis, 17.7 Million people died from CVDs in 2015; this accounts for 31% of all global deaths
  • The total global cost of treating CVDs was $863 Billion in 2010; this is projected to reach approximately $1,100 Billion by 2030
  • 84 Million people in the U.S. suffer from some form of CVD
  • 15.8 Million Americans have Coronary Artery Disease (CAD)
  • Heart Failure affects 5 Million U.S. adults
  • Heart disease & stroke account for approximately $320 Billion of direct healthcare costs per year in the U.S.

My presentation will address the following key questions and issues:

  • What is the current “Gold Standard” of care today for each of these heart conditions and what are the 3 leading evolving technologies & related treatments to address these heart diseases through 2030:
    • Coronary Artery Disease (CAD)
    • Heart Failure
    • Heart Valve Disease
    • Cardiac Arrhythmias
    • Congenital Heart Defects
  • What are the leading medical device companies in each of these areas, what are their product roadmaps, and what evolving and advanced technologies are driving these product strategies? When will we see some of these medical breakthroughs integrated into routine practice?
  • Preventive Cardiology: What are some practical, proven, and duplicable?


Recent Publications

“Cardiac Stem Cell Therapies: The Next Revolution in Heart Failure Treatment”, BioInformant, March 14, 2017

Link: https://www.bioinformant.com/cardiac-stem-cell-therapies/

“NYU Stern Innovators – Alumni Paving the Way to the Future in Energy Monitoring & Management and Digital Media Software”, Global Innovation Magazine, February 2017 – Issue 10, pg. 20

Link:http://www.globalinnovationmagazine.com/magazine/feb2017/

What's the BIG DEAL about Diastolic Dysfunction? Here's What....”, LinkedIn – Pulse, October 14, 2016

Link: https://www.linkedin.com/pulse/whats-big-deal-          diastolic-dysfunction-heres-what-clifford-thornton

"A Fantastic Vessel-Clearing Innovation", Inventor's Digest, February 2016 Issue, pg. 19

Link:https://issuu.com/inventorsdigest/docs/inventorsdigestfebruary2016__1_

"A Totally New Healthcare System", Modern Health Talk, February 17, 2012

Link: http://www.mhealthtalk.com/new-healthcare-system/